Skip to main content
Clinical Trials/CTRI/2024/02/063354
CTRI/2024/02/063354
Not yet recruiting
Phase 4

The effect of intermittent theta burst repetitive transcranial magnetic stimulation in the treatment of chronic migraine: A double-blind sham-controlled trial. - <br >

Sujita Singh0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Sujita Singh
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Sujita Singh

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients with migraine, diagnosed according to the International Classification of Headache Disorders (ICHD\-3rd edition)
  • 2\.Age between 18\-60 years
  • 3\.Sex: all gender
  • 4\.Written informed consent for the study obtained from the participants.
  • 5\.With or without any prophylactic treatment.

Exclusion Criteria

  • 1\.Any other type of chronic or recurrent headache such as diagnosed as sinusitis, refractive errors, cervical spondylosis, and neurological conditions.
  • 2\.Neuropsychiatry disorders Organic brain conditions, History of severe head injury, epilepsy, space occupying lesion, trigeminal neuralgia, hydrocephalous, meningitis, and other pain conditions.
  • 3\.Otherwise physically healthy conditions
  • 4\.Psychogenic pain, tension headache, Somatoform pain disorder
  • 5\.Use of botulinum toxin in head or neck region in last 6 months.
  • 6\.Active phase of any major Psychiatry illness (Schizophrenia, Bipolar disorder), substance use disorder (except moderate tea and nicotine use).
  • 7\.Active phase of depression
  • 8\.Confirmed Pregnancy
  • Having cochlear implant, cardiac pacemaker and metal body implanted in the body.

Outcomes

Primary Outcomes

Not specified

Similar Trials